Nike (NKE) Reports Retirement of Dr. John C. Lechleiter from Board

April 23, 2019 4:43 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

NIKE, Inc. (NYSE: NKE) today announced that Dr. John C. Lechleiter, a director of the Company since 2009 and former Chairman, President and Chief Executive Officer of Eli Lilly and Company, has decided to retire and will not stand for re-election to the Board of Directors of NIKE, Inc. (the “Company”) at the September 2019 Annual Meeting of Shareholders (the “Annual Meeting”). Dr. Lechleiter’s decision to retire was due to scheduling conflicts with other boards on which he presently serves.

Dr. Lechleiter will continue to serve as a NIKE, Inc. director until the 2019 Annual Meeting. He will be succeeded by Michelle Peluso, a director since 2014, as Chairperson of the Corporate Responsibility, Sustainability & Governance Committee of the Board.

“We’d like to thank John for his contributions as a valued and trusted advisor and steward since 2009. His insights as a business leader have been invaluable and we wish him well,” said Mark Parker, Chairman, President and CEO of NIKE, Inc. “We are also incredibly pleased that Michelle will succeed John as Chairperson of the Corporate Responsibility, Sustainability & Governance Committee. Her passion, commitment and leadership in the key strategic areas overseen by the Committee will help us build upon Nike’s leadership position.”

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Changes, Management Comments

Related Entities